YTHDF2 in hepatocellular carcinoma: Bridging m6A modification and cancer progression
Abstract YTH N6‐methyladenosine RNAbinding protein F2 (YTHDF2) is an N6‐methyladenosine (m6A) reader protein that mainly regulates the stability of methylated transcripts through mRNA decay. In the liver, YTHDF2 is involved in metabolic homeostasis, oxidative stress responses, and immune regulation.
Sijie Zang +7 more
wiley +1 more source
Comparative Efficacy of Promising Targets in the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Network Meta-analysis. [PDF]
Ni W +12 more
europepmc +1 more source
Age Does Not Affect Textbook Outcome After Liver Surgery Within an Enhanced Recovery Pathway
Textbook outcome in liver surgery (TOLS) is a novel comprehensive quality metric reflecting an ideal postoperative course. Data on TOLS in older adult patients remain limited. This study aimed to compare TOLS achievement between older adults and younger patients and to identify TOLS predictors.
Emilie Zhu +8 more
wiley +1 more source
Hepatocyte-derived lipid droplets in MASH: macrophage sensing and inflammation. [PDF]
Jin D, Zhao Y.
europepmc +1 more source
ABSTRACT Objective An increasing number of women of childbearing age worldwide are using glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and are advised to use effective contraception during treatment. Nevertheless, maternity services are encountering increasing numbers of women exposed to GLP‐1 RAs shortly before conception or during pregnancy ...
Katherine G. Y. Lau +6 more
wiley +1 more source
Reply to the Letter to the Editor: "Effects of rifaximin in fructose-induced steatohepatitis in rats". [PDF]
Celik NC +6 more
europepmc +1 more source
Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes +2 more
wiley +1 more source
Adipose tissue dysfunction and the liver: reframing MASH as the hepatic expression of systemic metabolic dysfunction. [PDF]
Corrao S, Argano C.
europepmc +1 more source
Abstract Background and aims Alcohol use disorder (AUD) follows a chronic, relapsing course but is often overlooked when alcohol consumption is minimal at the time of evaluation. We aimed to assess the prognostic impact of a prior AUD diagnosis on liver‐related outcomes in patients with presumed metabolic dysfunction‐associated steatotic liver disease (
Butros Fakhoury +6 more
wiley +1 more source
Will GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective. [PDF]
Pereira ENGDS, Rodrigues KL.
europepmc +1 more source

